Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
08 September 2014Website:
http://www.petvivo.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Wed, 03 Jul 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
PETV Latest News
MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, reported results for the fiscal year ended March 31, 2024. All comparisons are to the same year-ago period unless otherwise noted. The company will hold a conference call at 5:00 p.m. Eastern time today to discuss the results (see dial-in information below).
MINNEAPOLIS, MN, US, June 25, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, will hold a conference call on Friday, June 28, 2024 at 5:00 p.m. Eastern time to discuss results for the fiscal fourth quarter and year ended March 31, 2024. The financial results will be issued in a press release prior to the call.
MINNEAPOLIS, MN, US, June 06, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, has appointed Bryan Monninger to vice president of sales.
PetVivo Holdings, Inc. (PETV) Q3 2024 Earnings Call Transcript
MINNEAPOLIS, MN, US, Feb. 06, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Monday, February 12, 2024 after market close. The company will host a conference call to discuss these results at 4:00 p.m. CT (5:00 p.m. ET) on the same day.
PetVivo Holdings, Inc. (NASDAQ:PETV ) Q2 2024 Earnings Conference Call November 14, 2023 5:00 PM ET Company Participants John Dolan - Chief Business Development Officer & General Counsel John Lai - Chief Executive Officer & President Bob Folkes - Chief Financial Officer Conference Call Participants Operator Welcome, everyone, to the PetVivo Holdings, Inc., 2024 Fiscal Year Second Quarter Earnings Report. This is November 14, 2023, and I will now hand over to Mr.
MINNEAPOLIS, MN, US, Aug. 07, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Thursday, August 10, 2023 after market close. The company will host a conference call to discuss these results at 4:00 p.m. CT (5:00 p.m. ET) on the same day.
MINNEAPOLIS, MN, US, June 29, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for companion animals, announced it has rescheduled its earnings conference call for the year ending March 31, 2023. The call will now be held on Friday, June 30, 2023 at 10:00 AM ET (9:00 AM CT).
Developmental biomedical device company PetVivo Holdings Inc. OTCMKTS: PETV makes pet medical devices and therapeutics. What kind of medical devices would pets need?
MINNEAPOLIS, MN, US, June 26, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for companion animals, will report financial results for the year ending March 31, 2023, on Thursday, June 29, 2023 after market close. The company will host a conference call to discuss these results at 4:00 p.m. CT (5:00 p.m. ET) on the same day.
What type of business is PetVivo Holdings?
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
What sector is PetVivo Holdings in?
PetVivo Holdings is in the Healthcare sector
What industry is PetVivo Holdings in?
PetVivo Holdings is in the Medical Devices industry
What country is PetVivo Holdings from?
PetVivo Holdings is headquartered in United States
When did PetVivo Holdings go public?
PetVivo Holdings initial public offering (IPO) was on 08 September 2014
What is PetVivo Holdings website?
https://www.petvivo.com
Is PetVivo Holdings in the S&P 500?
No, PetVivo Holdings is not included in the S&P 500 index
Is PetVivo Holdings in the NASDAQ 100?
No, PetVivo Holdings is not included in the NASDAQ 100 index
Is PetVivo Holdings in the Dow Jones?
No, PetVivo Holdings is not included in the Dow Jones index
When does PetVivo Holdings report earnings?
Next earnings report date is not announced yet